New diagnostic tests for pneumonia: What is their role in clinical practice?

Clinics in Chest Medicine

Volumn 32, Issue 3, 2011, Pages 417-430

  File Jr , Thomas M ^a,b  

^a Northeastern Ohio Medical University   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

Author keywords

Diagnosis; Molecular studies; Pneumonia

Indexed keywords

AMOXICILLIN; ANTIGEN; BETA LACTAM ANTIBIOTIC; PNEUMOCOCCAL URINARY ANTIGEN; PROCALCITONIN; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; LEGIONELLA; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; URINARY ANTIGEN TESTING;

ANTIGENS, BACTERIAL; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS;

EID: 80051861303     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.05.011     Document Type: Review

References (66)

1. Fine M.J., Stone R.A., Singer D.E., et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1999, 159:970-980.
2. Read R.C. Evidence-based medicine: empiric antibiotic therapy in community-acquired pneumonia. J Infect 1999, 39:171-178.
3. van der Eerden M.M., Vlaspolder F., de Graaff C.S., et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomized study. Thorax 2005, 60(8):672-678.
4. File T.M., Niederman M.S. Antimicrobial therapy of community-acquired pneumonia. Infect Dis Clin North Am 2004, 18:993.
5. Sharuatzadeh M.R., Marrie T.J. Does sputum culture affect the management and/or the outcome of community-acquired pneumonia?. East Mediterr Health J 2009, 15:792-799.
6. Campbell S.G., Marrie T.J., Anstey R., et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003, 123:1142-1150.
7. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27.
8. Yu V.L., Stout J.E. Rapid diagnostic testing for community acquired pneumonia: can innovative technology for clinical microbiology be exploited?. Chest 2009, 136:1618-1621.
9. Bartlett J.G. Decline in microbial studies for patients with pulmonary infections. Clin Infect Dis 2004, 39:170-172.
10. Smith M.D., Derrington P., Evans P., et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol 2003, 41:2810-2813. 92.
11. Gutierrez F., Masia M., Rodriguez J.C., et al. Evaluation of the immunochromatographic binax NOW assay for detection of Streptococcus pneumoniae urinaryantigen in a prospective study of community-acquired pneumonia. Clin Infect Dis 2003, 36:286-292.
12. Dominguez J., Blanco S., Rodrigo C., et al. Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol 2003, 41:2161-2163.
13. Selickman J., Paxos M., File T.M., et al. Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia. Diagn Microbiol Infect Dis 2010, 67(2):129-133.
14. Samra Z., Shmuely H., Nahum E., et al. Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis. Diagn Microbiol Infect Dis 2003, 45(4):237-240.
15. Binax, Portland (ME). Binax NOW Streptococcus pneumoniae urinary antigen test package insert. Available at: Accessed November 1, 2011. http://binax.com.
16. Doern G.V. Detection of selected fastidious bacteria. Clin Infect Dis 2000, 30:166-173.
17. Stout J.E., Yu V.L. Legionellosis. N Engl J Med 1997, 337:682-687.
18. Waterer G.W., Baselski V.S., Wunderink R.G. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint. Am J Med 2001, 110:41-48.
19. Helbig J.H., Uldum S.A., Luck P.C., et al. Detection of Legionella pneumophila antigen in urine samples by the Binax NOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urinary Antigen EIA. J Med Microbiol 2001, 50:509-516.
20. Murdoch D.R., Laing R.T., Mills G.D., et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol 2001, 39:3495-3498.
21. Shimada T., Noguchi Y., Jackson J.L., et al. Systematic review and meta-analysis: urinary antigen tests for legionellosis. Chest 2009, 136:1576-1585.
22. Mahlen S.D. Applications of molecular diagnostics. Textbook of diagnostic microbiology 2007, 272-302. Saunders Elsevier, St Louis (MO). 3rd edition. C.R. Mahon, D.C. Lehman, G. Manuselis (Eds.).
23. Nolte F.S., Caliendo A.M. Molecular detection and identification of microorganisms. Manual of clinical microbiology 2007, 218-244. ASM Press, Washington, DC. 9th edition. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds.).
24. Espy M.J., Uhl J.R., Sloan L.M., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006, 19:165-256.
25. Nolte F.S. Molecular diagnostics for detection of bacterial and viral pathogens in community-acquired pneumonia. Clin Infect Dis 2008, 47(Suppl 3):S123-S126.
26. teWitt R., van Leeuwen W.B. Specific diagnostic tests for atypical respiratory tract pathogens. Infect Dis Clin North Am 2010, 24:229.
27. Chan Y.R., Morris A. Molecular diagnostic methods in pneumonia. Curr Opin Infect Dis 2007, 20:157-164.
28. Murdoch D.R., Jennings L.C., Bhat N., et al. Emerging advances in rapid diagnostic of respiratory infections. Infect Dis Clin North Am 2010, 24:791-807. 112, 713-727.
29. Murdoch D.R., O'Brien K.L., Scott J.A., et al. Breathing new life into pneumonia diagnostics. J Clin Microbiol 2009, 47:3405-3408.
30. Butler J.C., Bosshardt S.C., Phelan M., et al. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults. J Infect Dis 2003, 187:1416-1423.
31. Saukkoriipi A., Palmu A., Kilpi T., et al. Real-time quantitative PCR for the detection of Streptococcus pneumoniae in the middle ear fluid of children with acute otitis media. Mol Cell Probes 2002, 16:385-390.
32. Falguera M., Lopez A., Nogues A., et al. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 2002, 122:2212-2216.
33. Yang S., Lin S., Khalil A., et al. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol 2005, 43:3211-3226.
34. Smith M.D., Sheppard C.L., Hogan A., et al. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J Clin Microbiol 2009, 47:1046-1049.
35. Avni T., Mansur N., Leibovici L., et al. PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol 2010, 48:489-496.
36. She R.C., Thurber A., Hymas W.C., et al. Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections. J Clin Microbiol 2010, 48:3380-3382.
37. Kerdsin A., Uchida R., Verathamjamrus C., et al. Development of triplex SYBR green real-time PCR for detecting Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella spp. without extraction of DNA. Jpn J Infect Dis 2010, 63:173-180.
38. Kim N.H., Lee J.A., Eun B.W., et al. Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children. Pediatr Infect Dis J 2007, 26:897-903.
39. Liu F.C., Chen P.Y., Huang F.L., et al. Rapid diagnosis of Mycoplasma pneumoniae infection in children by polymerase chain reaction. J Microbiol Immunol Infect 2007, 40:507-512.
40. Cloud J.L., Carroll K.C., Pixton P., et al. Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation. J Clin Microbiol 2000, 38:1709-1712.
41. Diederen B.M., Van Der Eerden M.M., Vlaspolder F., et al. Detection of respiratory viruses and Legionella spp. by real-time polymerase chain reaction in patients with community acquired pneumonia. Scand J Infect Dis 2009, 41(1):45-50.
42. Morozumi M., Ito A., Murayama S.Y., et al. Assessment of real-time PCR for diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients. Can J Microbiol 2006, 52:125-129.
43. van Elden L.J., van Kraaij M.G., Nijhuis M., et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 2002, 34(2):177-183.
44. Fox J.D. Nucleic acid amplification tests for detection of respiratory viruses. J Clin Virol 2007, 40(Suppl 1):S15-S23.
45. Mahony J.B. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 2008, 21:716-747.
46. Templeton K.E., Scheltinga S.A., Beersma M.F., et al. Rapid and sensitive method using multiplex real-time PCR for the diagnosis of infections by influenza a, influenza b, respiratory syncytial virus, parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 2004, 42:1564-1569.
47. Lieberman D., Shimoni A., Shemer-Avni Y., et al. Respiratory viruses in adults with community-acquired pneumonia. Chest 2010, 138:811-816.
48. Barry M.A. Review of influenza diagnosis and treatment. JAMA 2010, 304:671-678.
49. Johansson N., Mats K., Tiveljung-Lindell A., et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010, 50:202-209.
50. Niederman M.S. Viral community-acquired pneumonia. If we do not diagnose it and do not treat it, can it still hurt us?. Chest 2010, 138:767-769.
51. Guchev I.A., Yu V.L., Sinopalmikov A., et al. Management of nonsevere pneumonia in military trainees with urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy. Clin Infect Dis 2005, 40:1608-1616.
52. Stralin K., Holmberg H. Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia. Clin Infect Dis 2005, 41:1209-1210.
53. Falguera M., Ruiz-Gonzalez A., Schoenenberger J.A., et al. Empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalized patients with community-acquired pneumonia. Thorax 2010, 65:101-106.
54. Oosterheert J.J., van Loon A.M., Schuurman R., et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005, 41:1438-1444.
55. Murdoch D.R. Impact of rapid microbiological testing on the management of lower respiratory tract infection. Clin Infect Dis 2005, 41:1445-1447.
56. Yu V. Comparing narrow-spectrum antimicrobial therapy to standard of care in patients with community-acquired pneumonia [Press release]. Available at:, Accessed January 13, 2011. http://www.nih.gov/news/health/oct2010/niaid-19.htm.
57. Niederman M.S. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin Infect Dis 2008, 47:S127-S132.
58. Schuetz P., Albrich W., Christ-Crain M., et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010, 8:575-587.
59. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363:600.
60. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84.
61. Schuetz P., Christ-Crain M., Thomann R., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302:1059.
62. Briel M., Schuetz P., Mueller B., et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008, 168:2000-2007.
63. Burkhardt O., Ewig S., Haagen U., et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010, 36:601.
64. Masiá M., Gutiérrez F., Shum C., et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patient's outcome research team pneumonia severity index. Chest 2005, 128:2223.
65. Boussekey N., Leroy O., Alfandari S., et al. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006, 32:469.
66. Schuetz P., Suter-Widmer I., Chaudri A., et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J 2011, 37(2):384-392.